Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype.
The risk of lung cancer in smokers was examined based on the debrisoquine metabolic phenotype and on exposure to occupational lung carcinogens, specifically asbestos and polycyclic aromatic hydrocarbons. Extensive metabolizers of debrisoquine are at a 4-fold increased risk for lung cancer compared to poor metabolizers, after adjustment for age, sex, and smoking (pack-years), when only occupationally unexposed subjects are considered. Increased risk related to the debrisoquine metabolic phenotype was greatest for squamous and small cell histologies, and least for the adenocarcinoma subtype. Men with a history of exposure to occupational carcinogens had significantly increased risk of lung cancer (relative risk = 2.8), after adjustment for age and smoking. Considering the combined effect of the high risk extensive metabolizers debrisoquine metabolic phenotype and likely occupational exposure to asbestos, the relative excess risk for lung cancer was 18-fold. This finding is consistent with a synergism in risk between the ability to extensively metabolize debrisoquine and occupational exposure to lung carcinogens in male smokers. Debrisoquine phenotyping has potential for identifying carcinogen-exposed workers at high risk of lung cancer.
Caporaso
N
N
Environmental Epidemiology Branch, National Cancer Institute, Bethesda, MD 20892.
Hayes
R B
RB
Dosemeci
M
M
Hoover
R
R
Ayesh
R
R
Hetzel
M
M
Idle
J
J
D001194:Asbestos; D003647:Debrisoquin / Q000378:metabolism*; D005260:Female; D006801:Humans; D007546:Isoquinolines / Q000378:metabolism*; D008173:Lung Diseases, Obstructive / Q000453:epidemiology; D008175:Lung Neoplasms / Q000453:epidemiology*; D008297:Male; D009784:Occupational Diseases / Q000453:epidemiology*; D010084:Oxidation-Reduction; D011083:Polycyclic Compounds; D012307:Risk Factors; D012907:Smoking
D007546:Isoquinolines; D011083:Polycyclic Compounds; D001194:Asbestos; D003647:Debrisoquin